Skip to content
akaturk Academic measurement

Article detail · 2024

Therapeutic Potential of Silymarin in Mitigating Paclitaxel-Induced Hepatotoxicity and Nephrotoxicity: Insights into Oxidative Stress, Inflammation, and Apoptosis in Rats

Balkan Medical Journal

YÖKSİS OpenAlex Open access · diamond SJR Q2 JCR Q1 TR Index Citations 16 Top 10% Percentile 95.3% FWCI 4.44
Year
2024
ISSN
2146-3123
Type
article

Data source split

  • YÖKSİS YÖKSİS article record
  • OpenAlex OpenAlex enrichment (abstract, citations, topics)

Abstract

English (OpenAlex)

Background: Paclitaxel (PAX) is a widely used chemotherapy drug for various cancer types but often induces significant toxicity in multiple organ systems. Silymarin (SIL), a natural flavonoid, has shown therapeutic potential due to its multiple benefits. Aims: To evaluate the therapeutic efficacy of SIL in mitigating liver and kidney damage induced by PAX in rats, focusing on oxidative stress, inflammation, and apoptosis pathways. Study Design: Experimental animal model. Methods: The study included 28 male Wistar rats aged 12-14 weeks weighing 270-300 g. The rats were divided into four groups: control, SIL, PAX, and PAX + SIL, with seven in each group. The rats received intraperitoneal (i.p.) injections at a dose of 2 mg per kilogram of body weight of PAX for 5 successive days, followed by oral gavage with 200 mg/kg body mass of SIL for 10 uninterrupted days. We examined the effect of SIL on specific serum biochemical parameters using an autoanalyzer and rat-specific kits. The spectrophotometric methods was used to investigate oxidative stress indicators in kidney and liver tissues. Aquaporin-2 (AQP-2), B-cell lymphoma-2 (Bcl-2), cysteine aspartate-specific protease-3 (caspase-3), interleukin-6 (IL-6), nuclear factor kappa B (NF-κB), and streptavidin-biotin staining were used to assess immunoreactivity in PAX-induced liver and kidney injury models. Results: < 0.05). Conclusion: Our findings indicate the potential of SIL to alleviate PAX-induced liver and kidney damage in rats by reducing oxidative stress, inflammation, and apoptotic processes.

Topics

  • Silymarin and Mushroom Poisoning
  • Chemotherapy-induced organ toxicity mitigation
  • Drug-Induced Hepatotoxicity and Protection

Primary topic Silymarin and Mushroom Poisoning

Authors

  1. SEDA YAKUT
  2. TUĞÇE TUTAR BİNGÖL ÜNİVERSİTESİ
  3. CÜNEYT ÇAĞLAYAN
  4. AYKUT ULUCAN BİNGÖL ÜNİVERSİTESİ
  5. FATİH MEHMET KANDEMİR
  6. ADEM KARA ERZURUM TEKNİK ÜNİVERSİTESİ
  7. TURGUT ANUK